EAR

NASDAQ

Eargo Inc.

SectorHealth CareIndustryMedical SpecialitiesIPO2020

$2.57-0.06 (-2.28%)

News25/Ratings3

Eargo, Inc., a medical device company, develops and sells hearing aids to assist people with hearing loss in the United States. It sells its products through online stores. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was founded in 2010 and is headquartered in San Jose, California.

Latest news

25 items

787dSEC
SEC Form 15-12G filed by Eargo Inc.
15-12G - Eargo, Inc. (0001719395) (Filer)
792dSEC
SEC Form S-8 POS filed by Eargo Inc.
S-8 POS - Eargo, Inc. (0001719395) (Filer)
792dSEC
SEC Form S-8 POS filed by Eargo Inc.
S-8 POS - Eargo, Inc. (0001719395) (Filer)
792dSEC
SEC Form S-8 POS filed by Eargo Inc.
S-8 POS - Eargo, Inc. (0001719395) (Filer)
793dINSIDER
Brownie William returned 296 shares to the company, closing all direct ownership in the company (SEC Form 4)
4 - Eargo, Inc. (0001719395) (Issuer)
793dINSIDER
SEC Form 4 filed by Narula Onkarr
4 - Eargo, Inc. (0001719395) (Issuer)
793dINSIDER
Wu David James returned 25,463 shares to the company, closing all direct ownership in the company (SEC Form 4)
4 - Eargo, Inc. (0001719395) (Issuer)
793dINSIDER
SEC Form 4 filed by Sabet-Peyman Afshin Justin
4 - Eargo, Inc. (0001719395) (Issuer)
793dINSIDER
SEC Form 4 filed by Bayne Katie J
4 - Eargo, Inc. (0001719395) (Issuer)
793dINSIDER
SEC Form 4 filed by Spence Donald J
4 - Eargo, Inc. (0001719395) (Issuer)
793dINSIDER
Thorpe Mark returned 32 shares to the company, closing all direct ownership in the company (SEC Form 4)
4 - Eargo, Inc. (0001719395) (Issuer)
793dINSIDER
SEC Form 4 filed by Garg Trit
4 - Eargo, Inc. (0001719395) (Issuer)
797dSEC
SEC Form RW filed by Eargo Inc.
RW - Eargo, Inc. (0001719395) (Filer)
797d13D/G
SEC Form SC 13D/A filed by Eargo Inc. (Amendment)
SC 13D/A - Eargo, Inc. (0001719395) (Subject)
797dSEC
SEC Form SC 13E3/A filed by Eargo Inc. (Amendment)
SC 13E3/A - Eargo, Inc. (0001719395) (Subject)
797dSEC
SEC Form 25-NSE filed by Eargo Inc.
25-NSE - Eargo, Inc. (0001719395) (Subject)
797dSEC
Eargo Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
8-K - Eargo, Inc. (0001719395) (Filer)
799dSEC
Eargo Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
8-K - Eargo, Inc. (0001719395) (Filer)
806dSEC
SEC Form DEFA14A filed by Eargo Inc.
DEFA14A - Eargo, Inc. (0001719395) (Filer)
813dPR
Eargo Debuts Two New Devices, Expanding Portfolio of Hearing Wellness Offerings
SAN JOSE, Calif., Jan. 31, 2024 (GLOBE NEWSWIRE) -- This quarter, Eargo, Inc. launches two new over-the-counter (OTC) hearing wellness devices, Eargo SE (launching today) and LINK by Eargo (launching in the first quarter of 2024). The new devices expand the brand's portfolio of offerings with a new earbud form factor and a completely-in-canal option focused on Eargo signature essentials. For over a decade, Eargo has set the industry standard for pairing award-winning discreet and effortless hearing devices with ongoing expert support. These newest devices address additional consumer needs around functionality, design and experience. Key highlights of each product include: Eargo SE (MSRP$1
828dSEC
SEC Form SC 13E3/A filed by Eargo Inc. (Amendment)
SC 13E3/A - Eargo, Inc. (0001719395) (Subject)
828dSEC
SEC Form DEFM14A filed by Eargo Inc.
DEFM14A - Eargo, Inc. (0001719395) (Filer)
839dSEC
SEC Form SC 13E3/A filed by Eargo Inc. (Amendment)
SC 13E3/A - Eargo, Inc. (0001719395) (Subject)
839dSEC
SEC Form PRER14A filed by Eargo Inc.
PRER14A - Eargo, Inc. (0001719395) (Filer)
847dSEC
SEC Form SC 13E3/A filed by Eargo Inc. (Amendment)
SC 13E3/A - Eargo, Inc. (0001719395) (Subject)